Fundraising Fox

PostEra

YC W20

Boston, US · Founded 2019 · Delaware corporation · 40 employees · 6 known investors

postera.ai

Postera uses artificial intelligence and computational chemistry to accelerate drug discovery for pharmaceutical companies. The platform combines machine learning, medicinal chemistry, and software engineering to improve the drug development process.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesAI-powered Drug DiscoveryMachine LearningCOVID-19in /postera-ai/@PostEra_AIycombinator.com ↗
PostEra website preview

Founders & leadership· Y Combinator alumni (W20)

ALAlpha Lee
Alpha LeeinFounder
MRMatthew Robinson
Matthew RobinsoninFounder

Investors · 6

Competitors · 5

by search overlap

Companies competing with PostEra for the same Google search keywords, organic and paid, via search-intersection analysis.

Reported raises · per SEC filings

Form D private placements
$26.1MraisedJan 2022 · 21 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew RobinsonExecutive Officer, Director
  • Alpha LeeExecutive Officer, Director
  • Aaron MorrisExecutive Officer, Director
Offering amount
$27.5M
Amount sold
$26.1M
First sale
Dec 2021
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news